Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00781599 · ClinicalTrials.gov registry record · NA
Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers
A NA study of Smokers, sponsored by Nikki Nollen, PhD, MA.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT00781599: Completed NA study of Smokers, sponsored by Nikki Nollen, PhD, MA.
NCT00781599 is a NA study of Smokers that has completed, run by Nikki Nollen, PhD, MA. The registered enrollment target is 72 participants, above the 41-participant average among 3 other Smokers trials with a reported enrollment target (76% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00781599, a NA study of Smokers, has completed, sponsored by Nikki Nollen, PhD, MA.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
Little is known about the support needed to improve compliance with Chantix for smoking cessation. This is a two arm pilot study of African American smokers to provide varying levels of side effect management and compliance support during a 12 week treatment period. The primary aim of the study is to estimate the effect of induction support compared to standard care in increasing compliance with Chantix at month 3
Primary Outcome
Compliance with Chantix calculated as the total doses taken over the total number of doses prescribed. Adherence was measured by pill counts. Measurements taken during monthly medication refill visits. There was no specific predetermined cutoff number on the scale which determined non-compliance. All results from compliance calculations are included in the table.
Conditions Studied
Interventions
- BEHAVIORAL Adherence Counseling
- DRUG Chantix
- BEHAVIORAL Standard Counseling
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-03 |
| Phase | NA |
What the finished NCT00781599 record still lists
NCT00781599 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, above the 41-participant average among 3 other Smokers trials with a reported enrollment target (76% higher).
The record links to 1 condition, with Smokers appearing as the primary indexed condition, and to 3 interventions - of which Adherence Counseling is the first listed.
NCT00781599 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT00781599 about?
NCT00781599 is a clinical study titled "Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers". Little is known about the support needed to improve compliance with Chantix for smoking cessation. This is a two arm pilot study of African American smokers to provide varying levels of side effect management and compliance support during a 12 week treatment period. The primary aim of the study is t...
What is the current status of trial NCT00781599?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2008-10. Estimated completion is 2010-03.
What conditions does trial NCT00781599 study?
This clinical trial studies the following conditions: Smokers.
What interventions are being tested in trial NCT00781599?
The interventions under investigation include: Adherence Counseling (BEHAVIORAL), Chantix (DRUG), Standard Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00781599?
This trial is sponsored by Nikki Nollen, PhD, MA, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00781599 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smokers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia